-
UK Government announces first-of-its-kind Vaccines Manufacturing Innovation Centre
pharmafile
December 07, 2018
Plans for a Vaccines Manufacturing Innovation Centre in the UK have been unveiled by Business Secretary Greg Clark, in a bid to help tackle deadly diseases around the world and boost growth of the country’s £70 billion life sciences industry.
-
Outbreak alliance hands Johnson & Johnson, Oxford $18.7M for MERS work and more
fiercepharma
September 29, 2018
CEPI, the global outbreak preparedness group, has been busy since it launched last year, raising more than $600 million and handing out grants to back research into neglected diseases. In its latest move, the coalition awarded ...
-
Oxford Nanopore raises $140 M led by Asian investors
biospectrumasia
March 23, 2018
This expanded range is designed to address all parts of the existing DNA-sequencing market, as well as enabling new applications that can only be performed with a real-time, scalable, long-read technology.
-
University of Oxford gains access to biomarker profiling technology
pharmafiles
May 10, 2017
The University of Oxford has announced that it will benefit from Nightingale Health’s biomarker analysis technology. The Finnish company will install its technology in the Nuffield Department of Population Health (NPDH), in the Wolfson Laboratory.